Upstream Bio, Inc.
UPB
$6.75
$0.396.13%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 54.79% | -2.20% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 54.79% | -2.20% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | 54.79% | -2.20% | |||
| SG&A Expenses | 21.27% | 20.28% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -4.67% | 21.60% | |||
| Operating Income | 5.53% | -22.03% | |||
| Income Before Tax | 4.40% | -25.81% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 4.40% | -25.81% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 4.40% | -25.81% | |||
| EBIT | 5.53% | -22.03% | |||
| EBITDA | 5.52% | -22.02% | |||
| EPS Basic | 4.83% | -25.44% | |||
| Normalized Basic EPS | 4.83% | -25.44% | |||
| EPS Diluted | 4.83% | -25.44% | |||
| Normalized Diluted EPS | 4.83% | -25.44% | |||
| Average Basic Shares Outstanding | 0.45% | 0.29% | |||
| Average Diluted Shares Outstanding | 0.45% | 0.29% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||